Literature DB >> 29283816

Impact of Disease Disclosure on Stigma: An Experimental Investigation of College Students' Reactions to Inflammatory Bowel Disease.

Jacob A Rohde1, Yue Wang2, Chelsea M Cutino2, Bonnie K Dickson2, Marisa C Bernal2, Serena Bronda2, Aizhou Liu2, Sai Indira Priyadarshini2, Ling Guo3, Jason S Reich3, Francis A Farraye3.   

Abstract

Inflammatory bowel disease (IBD) is a serious chronic illness that affects 1 in 200 people in the United States with the majority of new cases of IBD diagnosed in young people under the age of 35. Despite the growing number of people who are diagnosed each year, the consequences of health-related stigma faced by young people grappling with the effects of IBD are understudied. This experimental investigation explored the existence of enacted stigma among college students, a population that faces many social and psychological challenges due to the added emotional stresses brought about by the transition from high school and adolescence to college and adulthood. Results indicate that enacted stigma among college students toward other students with IBD decreases when disclosure of the disease is present. Results also suggest that greater knowledge of the nature and symptoms of IBD positively correlates to decreased stigma.

Entities:  

Mesh:

Year:  2017        PMID: 29283816     DOI: 10.1080/10810730.2017.1392653

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  2 in total

1.  "I Don't Like to Make a Big Thing out of It": A Qualitative Interview-Based Study Exploring Factors Affecting Whether Young People Tell or Do Not Tell Their Friends about Their IBD.

Authors:  Bernie Carter; Alison Rouncefield-Swales; Lucy Bray; Lucy Blake; Stephen Allen; Chris Probert; Kay Crook; Pamela Qualter
Journal:  Int J Chronic Dis       Date:  2020-06-11

Review 2.  Stigmatisation and resilience in inflammatory bowel disease.

Authors:  Marco Vincenzo Lenti; Sara Cococcia; Jihane Ghorayeb; Antonio Di Sabatino; Christian P Selinger
Journal:  Intern Emerg Med       Date:  2019-12-31       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.